1.
Schlesinger T, Kircik L, Armstrong A, Berman B, Bhatia N, Del Rosso J, Lebwohl M, Patel V, Rigel D, Narayanan S, Koscielny V, Kasujee I. Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s162. Available from: https://jofskin.org/index.php/skin/article/view/2048